A multi-center, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

Abstract Objectives Rituximab (RTX) may favorably affect lung function and skin fibrosis in patients with systemic sclerosis (SSc). We aimed to assess long term efficacy and safety of RTX in SSc compared to standard treatment. Methods Fifty one patients with SSc-associated interstitial lung disease...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in arthritis and rheumatism 2016
Hauptverfasser:	Daoussis, Dimitrios, M.D, Melissaropoulos, Konstantinos, M.D, Sakellaropoulos, Georgios, Antonopoulos, Ioannis, M.D, Markatseli, Theodora E., M.D, Simopoulou, Theodora, M.D, Georgiou, Panagiotis, M.D, Andonopoulos, Andrew P., M.D, Drosos, Alexandros A., M.D, Sakkas, Lazaros, M.D., DM, PhD(UK), FRCP(UK), Liossis, Stamatis-Nick, M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Rheumatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!